XTL Biopharmaceuticals Ltd. XTLB
NASDAQ
| 09/30/2025 | 12/31/2024 | 06/30/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 76.00K | 1.14M | 1.59M | 2.01M | |
| Total Receivables | -- | 99.00K | 304.00K | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | 51.00K | 128.00K | 29.00K | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 90.00K | 47.00K | -- | 11.00K | |
| Total Current Assets | 166.00K | 1.34M | 2.02M | 2.05M | |
|
|
|||||
| Total Current Assets | 166.00K | 1.34M | 2.02M | 2.05M | |
| Net Property, Plant & Equipment | -- | 187.00K | -- | -- | |
| Long-term Investments | -- | 3.19M | -- | -- | |
| Goodwill | -- | 3.19M | -- | -- | |
| Total Other Intangibles | -- | 3.82M | 380.00K | 380.00K | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | 14.00K | -- | -- | |
| Total Assets | 166.00K | 8.55M | 2.40M | 2.43M | |
|
|
|||||
| Total Accounts Payable | 20.00K | 227.00K | 165.00K | 1.00K | |
| Total Accrued Expenses | 131.00K | 545.00K | -- | 205.00K | |
| Short-term Debt | -- | 138.00K | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 269.00K | 1.30M | -- | -- | |
| Total Other Current Liabilities | 269.00K | 1.30M | -- | -- | |
| Total Current Liabilities | 420.00K | 2.21M | 165.00K | 206.00K | |
|
|
|||||
| Total Current Liabilities | 420.00K | 2.21M | 165.00K | 206.00K | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | 138.00K | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | 908.00K | -- | -- | |
| Total Liabilities | 420.00K | 3.12M | 165.00K | 206.00K | |
|
|
|||||
| Common Stock & APIC | 165.36M | 164.42M | 160.45M | 160.45M | |
| Retained Earnings | -165.63M | -159.01M | -158.23M | -158.25M | |
| Treasury Stock & Other | 20.00K | 20.00K | 20.00K | 20.00K | |
| Total Common Equity | -254.00K | 5.44M | 2.23M | 2.22M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -254.00K | 5.44M | 2.23M | 2.22M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -254.00K | 5.44M | 2.23M | 2.22M | |
|
|
|||||